<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-04-28</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678389/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">scBOL: a universal cell type identification framework for single-cell and spatial transcriptomics data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678389-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: Over the past decade, single-cell transcriptomic technologies have experienced remarkable advancements, enabling the simultaneous profiling of gene expressions across thousands of individual cells. Cell type identification plays an essential role in exploring tissue heterogeneity and characterizing cell state differences. With more and more well-annotated reference data becoming available, massive automatic identification methods have sprung up to simplify the annotation process &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObLEhz8D3">SF downtown的著名牛排餐厅Mastro’s。想不到SF还有对着装有要求的餐厅。这里的Bone in Kansas strip十分美味。Fire Mongo也是一绝。 美国·联合广场 Union Squa...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oblehz8d3/">
    
    
    
    
    
      
    
    SF downtown的著名牛排餐厅Mastro’s。想不到SF还有对着装有要求的餐厅。这里的Bone in Kansas strip十分美味。Fire Mongo也是一绝。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·联合广场 Union Square Park<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/">https://tvax2.sinaimg.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObNQVjApF">2024 White House Correspondents Dinner - Colin Jost太损了，保持了Weekend Update一贯的阴阳怪气，还保持了作为白人男性的自黑。RFK Jr - Like his vaccinati...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obnqvjapf/">
    
    
    
    
    
      
    
    2024 White House Correspondents Dinner - Colin Jost太损了，保持了Weekend Update一贯的阴阳怪气，还保持了作为白人男性的自黑。RFK Jr - Like his vaccination card said, he doesn’t have a shot.  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObMsfeZ5b">很多人提到柳州，第一时间会想到螺蛳粉，其实柳州的工业文化也值得探访一下。一大早，我跑到柳江江畔的工业博物馆，这里的陈列主题是柳州从清末到当代的工业发展...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obmsfez5b/">
    
    
    
    
    
      
    
    很多人提到柳州，第一时间会想到螺蛳粉，其实柳州的工业文化也值得探访一下。一大早，我跑到柳江江畔的工业博物馆，这里的陈列主题是柳州从清末到当代的工业发展进程，从民间木质榨糖机到丰收牌拖拉机，从木炭汽车到用庚子赔款造的机床，一应俱全，很多都是有着百年历史的老机器老物件儿。布展十分用心，整个装修风格颇有蒸朋之感。徜徉其间，能感受到一种磅礴的气势，仿佛有一台巨大的机器在牵引着时代，隆隆前行。值得带孩子来看看，让他们亲身体会到，工业如何深刻地改变人类文明，改变这个国家的命运。<!-- raw HTML omitted --><!-- raw HTML omitted -->顺便，最后一张图，我差点看哭了。那是一台柳州产的鱼峰牌十五天金声木座钟。我爷爷奶奶家，就有这么一台座钟，一模一样。我小时候最喜欢的事，就是打开钟座后背，从里面掏出钥匙，插入正面的发条孔，咯吱咯吱地上发条。这是我童年最美好的回忆之一，没想到在这里重逢了。<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%96%E7%95%8C%E8%AF%BB%E4%B9%A6%E6%97%A5%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%96%E7%95%8C%E8%AF%BB%E4%B9%A6%E6%97%A5%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObMz8hrTz">刚刚在柳州工业博物馆，还看到一张相关的照片。自从写完大医之后，对这类题材格外敏锐。 查看图片 - 转发 @万_岁_红_颜:&amp;ensp;读书#读书##热门小说推荐##大医# ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obmz8hrtz/">
    
    
    
    
    
      
    
    刚刚在柳州工业博物馆，还看到一张相关的照片。自从写完大医之后，对这类题材格外敏锐。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a href=&ldquo;<a href="https://weibo.com/1722413652%22">https://weibo.com/1722413652&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObNmIftHr">嗦螺螺～嗦螺螺～ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obnmifthr/">
    
    
    
    
    
      
    
    嗦螺螺～嗦螺螺～ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRBq2oJS">新闻说了，没系安全带的安全部长。//@从心水工:这都能肋骨骨折 丫绝对没栓安全带//@包容万物恒河水:顶着几根肋骨骨折出院了，现在这节骨眼不敢躺。//@做手烫伤:...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrbq2ojs/">
    
    
    
    
    
      
    
    新闻说了，没系安全带的安全部长。//<!-- raw HTML omitted -->@从心水工<!-- raw HTML omitted -->:这都能肋骨骨折 丫绝对没栓安全带//<!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->:顶着几根肋骨骨折出院了，现在这节骨眼不敢躺。//<!-- raw HTML omitted -->@做手烫伤<!-- raw HTML omitted -->:本格维尔不是还在医院？内塔抓住时间差赶紧把协议签了<!-- raw HTML omitted -->&lt;img alt=&quot;[怒]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_nu-0ddf642bed.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_nu-0ddf642bed.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRG81oBH">🔻图1是印第安纳大学内的狙击手。🔻这枪包我认识，是eberlestock的，美国军警狙击手和猎手都爱用，便宜量又足。 [图片][图片][图片][图片][图片][图片][图片...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrg81obh/">
    
    
    
    
    
      
    
    🔻图1是印第安纳大学内的狙击手。<!-- raw HTML omitted -->🔻这枪包我认识，是eberlestock的，美国军警狙击手和猎手都爱用，便宜量又足。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRHY2LO9">你又不打猎你要链接干什么？//@不虚此行听布卿:有链接吗[二哈] - 转发 @包容万物恒河水:&amp;ensp;🔻图1是印第安纳大学内的狙击手。🔻这枪包我认识，是eberlesto...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrhy2lo9/">
    
    
    
    
    
      
    
    你又不打猎你要链接干什么？//<!-- raw HTML omitted -->@不虚此行听布卿<!-- raw HTML omitted -->:有链接吗<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻图1是印第安纳大学内的狙击手。<!-- raw HTML omitted -->🔻这枪包我认识，是eberlestock的，美国军警狙击手和猎手都爱用，便宜量又足。 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hp6ywdujorj20wi14ltp7.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hp6ywdujorj20wi14ltp7.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRJcfMxu">🔻卧槽 🔻网友分享 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrjcfmxu/">
    
    
    
    
    
      
    
    🔻卧槽 <!-- raw HTML omitted -->🔻网友分享 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRJcytVS">🔻艾布拉姆斯正在前往莫斯科！🔻via vk/warhistoryalconafter 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrjcytvs/">
    
    
    
    
    
      
    
    🔻艾布拉姆斯正在前往莫斯科！<!-- raw HTML omitted -->🔻via vk/warhistoryalconafter <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/HTnhOt6">https://f.video.weibocdn.com/o0/HTnhOt6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObROSwzJO">🔻阿根廷的通货膨胀率现在比委内瑞拉高 4 倍。🔻287% 🇦🇷 🔻68% 🇻🇪 🔻晚安。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obroswzjo/">
    
    
    
    
    
      
    
    🔻阿根廷的通货膨胀率现在比委内瑞拉高 4 倍。<!-- raw HTML omitted -->🔻287% 🇦🇷 <!-- raw HTML omitted -->🔻68% 🇻🇪 <!-- raw HTML omitted -->🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRPxD7WP">500刀的大猎包在北美打猎装备里当然算便宜，别看tb的价格。//@风中仓鼠:这叫便宜？ 评论配图 - 转发 @包容万物恒河水:&amp;ensp;🔻图1是印第安纳大学内的狙击手。...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrpxd7wp/">
    
    
    
    
    
      
    
    500刀的大猎包在北美打猎装备里当然算便宜，别看tb的价格。//<!-- raw HTML omitted -->@风中仓鼠<!-- raw HTML omitted -->:这叫便宜？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->评论配图<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻图1是印第安纳大学内的狙击手。&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRPZ2Igm">自重太大了，包内外基本都是两层甚至三层缝制，登山不好使。//@不虚此行听布卿:登山啊[二哈]//@包容万物恒河水:你又不打猎你要链接干什么？//@不虚此行听布卿:有...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrpz2igm/">
    
    
    
    
    
      
    
    自重太大了，包内外基本都是两层甚至三层缝制，登山不好使。//<!-- raw HTML omitted -->@不虚此行听布卿<!-- raw HTML omitted -->:登山啊<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->:你又不打猎你要链接干什么？//<!-- raw HTML omitted -->@不虚此行听布卿<!-- raw HTML omitted -->:有链接吗&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRz3e450">顶着几根肋骨骨折出院了，现在这节骨眼不敢躺。//@做手烫伤:本格维尔不是还在医院？内塔抓住时间差赶紧把协议签了[怒] - 转发 @包容万物恒河水:&amp;ensp;🔻现在以...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrz3e450/">
    
    
    
    
    
      
    
    顶着几根肋骨骨折出院了，现在这节骨眼不敢躺。//<!-- raw HTML omitted -->@做手烫伤<!-- raw HTML omitted -->:本格维尔不是还在医院？内塔抓住时间差赶紧把协议签了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻现在以色列的情况是：本尼甘茨、本格维尔和斯莫特里奇正在攻击内塔尼亚胡，威胁内塔尼亚胡要是按照“埃及大纲”和哈马斯谈判就要推动解散 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRzhCbX0">🔻阿联酋迪拜政府今天批准了阿勒马克图姆国际机场新航站楼的设计，并下令立即开始建设耗资 1280 亿迪拉姆（348.54亿美元）的航站楼。🔻阿勒马克图姆国际机场...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrzhcbx0/">
    
    
    
    
    
      
    
    🔻阿联酋迪拜政府今天批准了阿勒马克图姆国际机场新航站楼的设计，并下令立即开始建设耗资 1280 亿迪拉姆（348.54亿美元）的航站楼。<!-- raw HTML omitted -->🔻阿勒马克图姆国际机场将成为世界上最大的机场，该机场将有400个飞机登机口和五条平行跑道，最终吞吐量为2.6亿人次。这将是目前迪拜国际机场的五倍。未来几年，DXB的所有业务都将转移到迪拜国际机场。<!-- raw HTML omitted -->🔻新奇观。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hp6yibod11j20sg0zkqla.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1hp6yibod11j20sg0zkqla.jpg&quot;</a> referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObNjF9Jke">四舍五入也算是吃了烤雪豹👿 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obnjf9jke/">
    
    
    
    
    
      
    
    四舍五入也算是吃了烤雪豹👿 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObN0Or7GI">坏了 我剑网三有瘾了完了完了完了</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obn0or7gi/">
    
    
    
    
    
      
    
    坏了 我剑网三有瘾了完了完了完了  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObNMLoYP5">我爹说叫我把地扫了，我说让机器人扫，居然还问我说机器人哪里会扫得干净[举车]太炸裂了 - 转发 @多次婉拒久保织织:&amp;ensp;我有时候真的觉得我爸有病买了扫地机器...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obnmloyp5/">
    
    
    
    
    
      
    
    我爹说叫我把地扫了，我说让机器人扫，居然还问我说机器人哪里会扫得干净<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->太炸裂了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@多次婉拒久保织织<!-- raw HTML omitted -->: 我有时候真的觉得我爸有病<!-- raw HTML omitted -->买了扫地机器人把它电拔了然后叫我过去做卫生 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObNzkngT8">我有时候真的觉得我爸有病买了扫地机器人把它电拔了然后叫我过去做卫生</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obnzkngt8/">
    
    
    
    
    
      
    
    我有时候真的觉得我爸有病<!-- raw HTML omitted -->买了扫地机器人把它电拔了然后叫我过去做卫生  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPjVukY6">宝贝领带换一条[老师爱你] - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# .👔👔👔 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpjvuky6/">
    
    
    
    
    
      
    
    宝贝领带换一条<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPmTATju">头发长长🥹 - 转发 @山下美月教会:&amp;ensp;山下美月 ✨乃木のの通知✨今天的节目由菅原咲月（MC）和黑见明香为大家送上🌙⚾也分享了两人最近的疏忽小故事✨下...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpmtatju/">
    
    
    
    
    
      
    
    头发长长🥹<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->✨乃木のの通知✨<!-- raw HTML omitted --><!-- raw HTML omitted -->今天的节目由菅原咲月（MC）和黑见明香为大家送上🌙⚾<!-- raw HTML omitted -->也分享了两人最近的疏忽小 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPnN82jQ">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.seventeen blog大家好，我是久保史绪里。这将是我最后一次在Seventeen上写博客，我将从Seventeen毕业。6年零7...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpnn82jq/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObR7RnJAZ">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.nogizaka46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obr7rnjaz/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hp6sj71yfcj31kw16oq82.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hp6sj71yfcj31kw16oq82.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObRV3crMc">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 作为17杂模特更新了最后的博客。包含了感谢、一直以来的心情和爱意。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obrv3crmc/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigra">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigra</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObRV5pjX5">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里17ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obrv5pjx5/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->17ins <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObO9JE4aE">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.seventeen blog大家好，我是久保史绪里。这将是我最后一次在Seventeen上写博客，我将从Seventeen毕业。6年零7...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obo9je4ae/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObPtLDwli">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# .👔👔👔 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obptldwli/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObPtPbmtQ">转发微博 - 转发 @鈴木絢音字幕組:&amp;ensp;铃木绚音#鈴木絢音#via.CBC广播「大津功 と 鈴木絢音 の通になりた〜い！」官方X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obptpbmtq/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@鈴木絢音字幕組<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->铃木绚音<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%B4%E6%9C%A8">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%B4%E6%9C%A8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObQfwbO3f">分享图片 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obqfwbo3f/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObPJ02eex">公司里的人，有的天天加班忙的不行，还有人天天睡觉准时下班，公司就这么几个人，这种情况下为什么还会怪到员工头上？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obpj02eex/">
    
    
    
    
    
      
    
    公司里的人，有的天天加班忙的不行，还有人天天睡觉准时下班，公司就这么几个人，这种情况下为什么还会怪到员工头上？  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObRKyuNsA">发布了头条文章：《分出高下的镰仓十番棋——日本围棋百大奠基人017》 #围棋# 围棋 分出高下的镰仓十番棋——日本围棋百大奠基人017 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obrkyunsa/">
    
    
    
    
    
      
    
    发布了头条文章：《分出高下的镰仓十番棋——日本围棋百大奠基人017》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObO88kS1C">久保史绪里via.seventeen blog大家好，我是久保史绪里。这将是我最后一次在Seventeen上写博客，我将从Seventeen毕业。6年零7个月，真的非常感谢大家。我加入时只...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obo88ks1c/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObPdUgWdz">久保史绪里#shiorigram# .👔👔👔 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obpdugwdz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->👔👔👔 &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObQcLmXHm">久保史绪里via.nogizaka46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obqclmxhm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogizaka46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObRLGwGA4">久保史绪里#shiorigram# 作为17杂模特更新了最后的博客。包含了感谢、一直以来的心情和爱意。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obrlgwga4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObRQx77rh">久保史绪里17ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obrqx77rh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->17ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_ca">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_ca</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/363311417/answer/3481659454">猫哥的视界回答了问题: 美国为什么就是不放过俄罗斯？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-363311417-answer-3481659454/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695001516">量子位发表了文章: 国产GPU重大利好！“中国英伟达”千卡集群已就位</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695001516/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695052705">量子位发表了文章: 一键换装神器爆火，老黄换上抱抱脸T恤，CEO本人：我被替代了，和他争CEO职位争不过</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695052705/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695077270">量子位发表了文章: 国产多模态大模型开源！无条件免费商用，性能超Claude 3 Sonnet</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695077270/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695091742">量子位发表了文章: 人工几十万，AI几十块！国产玩家证明了AIGC视频商业化威力</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695091742/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695094298">量子位发表了文章: 突发！谷歌Python团队解散，PyTorch之父震惊</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695094298/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38671645/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Clinical Relevance of Pathological Diagnosis of Hirschsprung&#39;s Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38671645-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The ability of calretinin IHC to diagnose HD early and time-independently prevented repeated intestinal biopsies in our patient population and allowed us to perform a one-stage TERPT in the first months of life, reducing the number of enterostomies and restoring colonic continuity early. Patients undergoing transanal pull-through under the age of 3 months require a close follow-up to detect cases with bowel movement &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38671815/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Finite Element Analysis of Fixed Orthodontic Retainers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38671815-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The efficacy of retainers is a pivotal concern in orthodontic care. This study examined the biomechanical behaviour of retainers, particularly the influence of retainer stiffness and tooth resilience on force transmission and stress distribution. To do this, a finite element model was created of the lower jaw from the left to the right canine with a retainer attached on the oral side. Three levels of tooth resilience and variable retainer bending stiffness (influenced by retainer type, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672422/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672422-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alcohol-associated liver disease (ALD) is a substantial cause of morbidity and mortality worldwide and represents a spectrum of liver injury beginning with hepatic steatosis (fatty liver) progressing to inflammation and culminating in cirrhosis. Multiple factors contribute to ALD progression and disease severity. Here, we overview several crucial mechanisms related to ALD end-stage outcome development, such as epigenetic changes, cell death, hemolysis, hepatic stellate cells activation, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">GTADC: A Graph-Based Method for Inferring Cell Spatial Distribution in Cancer Tissues</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The heterogeneity of tumors poses a challenge for understanding cell interactions and constructing complex ecosystems within cancer tissues. Current research strategies integrate spatial transcriptomics (ST) and single-cell sequencing (scRNA-seq) data to thoroughly analyze this intricate system. However, traditional deep learning methods using scRNA-seq data tend to filter differentially expressed genes through statistical methods. In the context of cancer tissues, where cancer cells &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">GTADC: A Graph-Based Method for Inferring Cell Spatial Distribution in Cancer Tissues</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The heterogeneity of tumors poses a challenge for understanding cell interactions and constructing complex ecosystems within cancer tissues. Current research strategies integrate spatial transcriptomics (ST) and single-cell sequencing (scRNA-seq) data to thoroughly analyze this intricate system. However, traditional deep learning methods using scRNA-seq data tend to filter differentially expressed genes through statistical methods. In the context of cancer tissues, where cancer cells &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672572/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672572-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Breast cancer is the leading cause of cancer-related mortality among women in Germany and worldwide. This retrospective claims data analysis utilizing data from AOK Baden-Wuerttemberg, a major statutory German health insurance provider, aimed to construct and assess a real-world data breast cancer disease model. The study included 27,869 female breast cancer patients and 55,738 age-matched controls, analyzing data from 2010 to 2020. Three distinct breast cancer stages were analyzed: Stage &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672579/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672579-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our results demonstrate the cytotoxic efficacy of helium ion radiotherapy in pancreatic cancer in vitro as well as the capability of mMKM calculation and its value for biological plan optimization in helium ion therapy for pancreatic cancer. A combined treatment of helium irradiation and chemotherapy with gemcitabine leads to mainly additive cytotoxic effects in pancreatic cancer cell lines. The data generated in this study may serve as the radiobiological basis for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672669/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672669-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cytoreductive surgery (CRS) combined with hyperthermic intrathoracic chemoperfusion (HITOC) is a promising treatment strategy for pleural mesothelioma (PM). The aim of this study was to evaluate the impacts of this multimodal approach in combination with systemic treatment on disease-free survival (DFS) and overall survival (OS). In this retrospective multicenter study, clinical data from patients after CRS and HITOC for PM at four high-volume thoracic surgery departments in Germany &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672680/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672680-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chimeric antigen receptor (CAR) T-cell therapy has become a powerful treatment option in B-cell and plasma cell malignancies, and many patients have benefited from its use. To date, six CAR T-cell products have been approved by the FDA and EMA, and many more are being developed and investigated in clinical trials. The whole field of adoptive cell transfer has experienced an unbelievable development process, and we are now at the edge of a new era of immune therapies that will have its &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673467/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Comparison between Invasive Intervention and Conservative Treatment in Patients with In-Hospital Myocardial Infarctions: Results from the Regional Myocardial Infarction Registry of Saxony-Anhalt (RHESA) Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673467-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background/Objectives: In-hospital myocardial infarctions (AMIs) are less often treated with invasive intervention, compared to out-of-hospital AMIs. We aimed to identify the determinants of invasive intervention in patients with in-hospital AMIs and assess its association with mortality, compared to conservative treatment. Methods: This was a cross-sectional study of in-hospital AMIs in The Regional Myocardial Infarction Registry of Saxony-Anhalt. Patients' characteristics and outcomes &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Introduction: Cardiac transthyretin amyloidosis (ATTR) is a progressive, fatal disease leading to heart failure due to accumulation of amyloid fibrils in the interstitial space and may occur as a hereditary (ATTRv) or wild-type (ATTRwt) form. Guidelines recommend the use of ACE inhibitors (ACEis) and beta-blockers (BBs) as heart failure therapy (HFT) in all patients with symptomatic heart failure and reduced ejection fraction, independent of the underlying etiology. However, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">The General Movement Optimality Score-Revised (GMOS-R) with Socioeconomically Stratified Percentile Ranks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The general movement optimality score (GMOS) quantifies the details of general movements (GMs). We recently conducted psychometric analyses of the GMOS and developed a revised scoresheet. Consequently, the GMOS-Revised (GMOS-R) instrument necessitated validation using new percentile ranks. This study aimed to provide these percentile ranks for the GMOS-R and to investigate whether sex, preterm birth, or the infant&rsquo;s country of birth and residence affected the GMOS-R &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">The General Movement Optimality Score-Revised (GMOS-R) with Socioeconomically Stratified Percentile Ranks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The general movement optimality score (GMOS) quantifies the details of general movements (GMs). We recently conducted psychometric analyses of the GMOS and developed a revised scoresheet. Consequently, the GMOS-Revised (GMOS-R) instrument necessitated validation using new percentile ranks. This study aimed to provide these percentile ranks for the GMOS-R and to investigate whether sex, preterm birth, or the infant&rsquo;s country of birth and residence affected the GMOS-R &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673751/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673751-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Plant-derived multitarget compounds may represent a promising therapeutic strategy for multifactorial diseases, such as Alzheimer&rsquo;s disease (AD). Artemisinin and its derivatives were indicated to beneficially modulate various aspects of AD pathology in different AD animal models through the regulation of a wide range of different cellular processes, such as energy homeostasis, apoptosis, proliferation and inflammatory pathways. In this review, we aimed to provide an up-to-date overview of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673751/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673751-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Plant-derived multitarget compounds may represent a promising therapeutic strategy for multifactorial diseases, such as Alzheimer&rsquo;s disease (AD). Artemisinin and its derivatives were indicated to beneficially modulate various aspects of AD pathology in different AD animal models through the regulation of a wide range of different cellular processes, such as energy homeostasis, apoptosis, proliferation and inflammatory pathways. In this review, we aimed to provide an up-to-date overview of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">Graph Node Classification to Predict Autism Risk in Genes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study explores the genetic risk associations with autism spectrum disorder (ASD) using graph neural networks (GNNs), leveraging the Sfari dataset and protein interaction network (PIN) data. We built a gene network with genes as nodes, chromosome band location as node features, and gene interactions as edges. Graph models were employed to classify the autism risk associated with newly introduced genes (test set). Three classification tasks were undertaken to test the ability of our &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">Graph Node Classification to Predict Autism Risk in Genes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study explores the genetic risk associations with autism spectrum disorder (ASD) using graph neural networks (GNNs), leveraging the Sfari dataset and protein interaction network (PIN) data. We built a gene network with genes as nodes, chromosome band location as node features, and gene interactions as edges. Graph models were employed to classify the autism risk associated with newly introduced genes (test set). Three classification tasks were undertaken to test the ability of our &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674841/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674841-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Osteoporosis affects one in three women over the age of 50 and results in fragility fractures. Oestrogen deficiency during and after menopause exacerbates bone loss, accounting for higher prevalence of fragility fractures in women. The gut microbiota (GM) has been proposed as a key regulator of bone health, as it performs vital functions such as immune regulation and biosynthesis of vitamins. Therefore, GM modulation via probiotic supplementation has been proposed as a target for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674841/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674841-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Osteoporosis affects one in three women over the age of 50 and results in fragility fractures. Oestrogen deficiency during and after menopause exacerbates bone loss, accounting for higher prevalence of fragility fractures in women. The gut microbiota (GM) has been proposed as a key regulator of bone health, as it performs vital functions such as immune regulation and biosynthesis of vitamins. Therefore, GM modulation via probiotic supplementation has been proposed as a target for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675472/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675472-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    [^(177)Lu]Lu-PSMA-617 has recently been successfully approved by the FDA, the MHRA, Health Canada and the EMA as Pluvicto^(®). However, salivary gland (SG) and kidney toxicities account for its main dose-limiting side-effects, while its corresponding uptake and retention mechanisms still remain elusive. Recently, the presence of different ATP-binding cassette (ABC) transporters, such as human breast cancer resistance proteins (BCRP), multidrug resistance proteins &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675472/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675472-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    [^(177)Lu]Lu-PSMA-617 has recently been successfully approved by the FDA, the MHRA, Health Canada and the EMA as Pluvicto^(®). However, salivary gland (SG) and kidney toxicities account for its main dose-limiting side-effects, while its corresponding uptake and retention mechanisms still remain elusive. Recently, the presence of different ATP-binding cassette (ABC) transporters, such as human breast cancer resistance proteins (BCRP), multidrug resistance proteins &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675604-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detecting the unintended adverse reactions of drugs (ADRs) is a crucial concern in pharmacological research. The experimental validation of drug-ADR associations often entails expensive and time-consuming investigations. Thus, a computational model to predict ADRs from known associations is essential for enhanced efficiency and cost-effectiveness. Here, we propose BiMPADR, a novel model that integrates drug gene expression into adverse reaction features using a message passing neural network &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675604-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detecting the unintended adverse reactions of drugs (ADRs) is a crucial concern in pharmacological research. The experimental validation of drug-ADR associations often entails expensive and time-consuming investigations. Thus, a computational model to predict ADRs from known associations is essential for enhanced efficiency and cost-effectiveness. Here, we propose BiMPADR, a novel model that integrates drug gene expression into adverse reaction features using a message passing neural network &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675779/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675779-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients are first diagnosed in the advanced stages, where treatment options are limited. Here, we present a 49-year-old patient who was first diagnosed with stage III ovarian cancer. After the tumor progressed several times under guideline therapies with no more treatment options available at that time, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675779/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675779-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients are first diagnosed in the advanced stages, where treatment options are limited. Here, we present a 49-year-old patient who was first diagnosed with stage III ovarian cancer. After the tumor progressed several times under guideline therapies with no more treatment options available at that time, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nanoparticles show great promise as a platform for developing vaccines for the prevention of infectious disease. We have been investigating a method whereby nanocapsules can be formulated from protein, such that the final capsules contain only the cross-linked protein itself. Such nanocapsules are made using a silica templating system and can be customised in terms of size and porosity. Here we compare the construction and characteristics of nanocapsules from four different proteins: one a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nanoparticles show great promise as a platform for developing vaccines for the prevention of infectious disease. We have been investigating a method whereby nanocapsules can be formulated from protein, such that the final capsules contain only the cross-linked protein itself. Such nanocapsules are made using a silica templating system and can be customised in terms of size and porosity. Here we compare the construction and characteristics of nanocapsules from four different proteins: one a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">DMSO and Its Role in Differentiation Impact Efficacy of Human Adenovirus (HAdV) Infection in HepaRG Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Differentiated HepaRG cells are popular in vitro cell models for hepatotoxicity studies. Their differentiation is usually supported by the addition of dimethyl sulfoxide (DMSO), an amphipathic solvent widely used in biomedicine, for example, in potential novel therapeutic drugs and cryopreservation of oocytes. Recent studies have demonstrated drastic effects, especially on epigenetics and extracellular matrix composition, induced by DMSO, making its postulated inert character doubtful. In &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">DMSO and Its Role in Differentiation Impact Efficacy of Human Adenovirus (HAdV) Infection in HepaRG Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Differentiated HepaRG cells are popular in vitro cell models for hepatotoxicity studies. Their differentiation is usually supported by the addition of dimethyl sulfoxide (DMSO), an amphipathic solvent widely used in biomedicine, for example, in potential novel therapeutic drugs and cryopreservation of oocytes. Recent studies have demonstrated drastic effects, especially on epigenetics and extracellular matrix composition, induced by DMSO, making its postulated inert character doubtful. In &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676549/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Validation of a Simple Clinical Tool for Screening of Acute Lacunar Stroke - a substudy of the WAKE-UP trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676549-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Lacunar score had a very good specificity and NPV for screening of lacunar stroke. Implementation of this simple tool into clinical practice may help hyperacute management and guide patient selection in clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Temporal Association Between Atrial Fibrillation and Ischemic Stroke: Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This meta-analysis supports a temporal relationship between PAF and ischemic stroke within a 30-day window. Establishing this relationship is important for individualized risk prediction and targeted anticoagulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676623/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676623-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RATIONALE: A large proportion of stroke survivors will have long-lasting, debilitating neurological impairments, yet few efficacious medical treatment options are available. Etanercept inhibits binding of tumor necrosis factor to its receptor and is used in the treatment of inflammatory conditions. Perispinal subcutaneous injection followed by a supine, head down position may bypass the blood brain barrier. In observational studies and one small randomized controlled trial the majority &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676626/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676626-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MicroRNAs (miRNAs) are a subset of small non-coding single-stranded RNA molecules involved in the regulation of post-transcriptional gene expression of a variety of transcript targets. Therefore altered miRNA expression may result in the dysregulation of key genes and biological pathways that has been reported with the onset and progression of neurodegenerative diseases, such as Amyotrophic lateral sclerosis (ALS). ALS is marked by a progressive degeneration of motor neurons (MNs) present in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676804/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676804-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Colorectal cancer (CRC) is a significant global health concern, requiring effective preclinical models for studying its development and testing therapies. Mouse models have been used, including spontaneous tumors, carcinogen exposure, and tumor cell implantation as xenografts or at orthotopic sites. Here, we describe an orthotopic preclinical model of CRC, which provides a valuable tool for studying tumor growth and the tumor microenvironment, offering a more accurate representation of human &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676844/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">&#34;TiC-TUG&#34;: technology in clinical practice using the instrumented timed up and go test-a scoping review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676844-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Digitized assessments have a considerable potential to guide clinicial decision making and monitor progress and disease trajectories. The Timed Up and Go test (TUG) has been long established for assessment in geriatric medicine and instrumented versions (iTUG) have been developed and validated. This scoping review includes studies that applied the iTUG and aims to identify use cases to show where and how iTUG assessment could guide interventions and clinical management. The literature search &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Recognizing the opportunity to directly de-label no-risk penicillin allergies in community pharmacy: a mystery shopper experience</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings underscore a concerning knowledge and practice gap among community pharmacists regarding penicillin allergy assessment which warrants more support and education in the community pharmacy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240428181057&amp;v=2.18.0.post9&#43;e462414">Emerging immunotherapies in the Hodgkin Lymphoma Armamentarium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676917-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240428181057-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Brentuximab vedotin and the PD-1 inhibitors have improved outcomes for classic Hodgkin lymphoma (cHL), but better therapies are needed for patients who relapse after these agents. Based on improved understanding of cHL biology, there is a robust pipeline of novel therapies in development. In this review, we highlight emerging immunotherapeutic agents and combinations for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676928/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Protocol for generating and analyzing organ-on-chip using human and mouse intestinal organoids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676928-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Organ-on-chip technology is a powerful tool for in vitro modeling. Combining it with organoids overcomes lumen inaccessibility while preserving cellular diversity and function of the intestinal epithelium. Here, we present a protocol for generating and analyzing organ-on-chips using human and mouse intestinal organoids. This protocol covers organoid line establishment, single-cell dissociation, chip preparation, and seeding. It outlines procedures for permeability assays, RNA &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677014/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">POLAT: Protein function prediction based on soft mask graph network and residue-Label ATtention</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677014-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: Elucidating protein function is a central problem in biochemistry, genetics, and molecular biology. Developing computational methods for protein function prediction is critical due to the significant gap between sequence and functional data. Recent advances in protein structure prediction, which strongly correlates with function, make it feasible to use structure to predict function. However, current structure-based methods overlook the fact that individual residues may &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677039/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Robustness of radiomic features in healthy abdominal parenchyma of patients with repeated examinations on dual-layer dual-energy CT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677039-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Radiomic feature robustness obtained from cancer-free subjects with repeated examinations using a consistent protocol and CT scanner was limited, with first order features yielding the highest proportion of robust &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677380/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Determinants of circulating calcitriol in cardiovascular disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677380-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Circulating calcitriol may contribute to the risk of cardiovascular disease (CVD), but its regulation in patients with CVD is poorly characterized. We therefore aimed to assess determinants of circulating calcitriol in these patients. We analyzed 2183 independent samples from a large cohort of patients scheduled for coronary angiography and 1727 independent samples from different other cohorts from patients with a wide range of CVDs, including heart transplant candidates, to quantify &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677594/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677594-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The low CTEPH incidence rate after acute PE in the present analysis suggests low awareness of CTEPH. It further suggests a lack of systematic follow-up protocols for acute PE survivors in the real world. Improved implementation of existing recommendations on follow-up strategies post PE is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678011/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Linear interaction between replication and transcription shapes DNA break dynamics at recurrent DNA break Clusters</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678011-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recurrent DNA break clusters (RDCs) are replication-transcription collision hotspots; many are unique to neural progenitor cells. Through high-resolution replication sequencing and a capture-ligation assay in mouse neural progenitor cells experiencing replication stress, we unravel the replication features dictating RDC location and orientation. Most RDCs occur at the replication forks traversing timing transition regions (TTRs), where sparse replication origins connect unidirectional &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">One model to use them all: training a segmentation model with complementary datasets</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678102-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: By leveraging multiple datasets and applying mutual exclusion constraints, we developed a method that improves surgical scene segmentation performance without the need for fully annotated datasets. Our results demonstrate the feasibility of training a model on multiple complementary datasets. This paves the way for future work further alleviating the need for one specialized large, fully segmented dataset but instead the use of already existing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObCStBIpR">今天参加了我们选区一个小时的run for office 101培训，NPR之前也有类似的节目，但我们选区办的更有本选区针对性。进行培训的有Palo Alto city council，更有代...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obcstbipr/">
    
    
    
    
    
      
    
    今天参加了我们选区一个小时的run for office 101培训，NPR之前也有类似的节目，但我们选区办的更有本选区针对性。进行培训的有Palo Alto city council，更有代表了一百万人的加州州参议员Josh Becker。所以我觉得加州的elected officials比东海岸要平易近人很多，因为你经常能在普通选区活动中见到他们。<!-- raw HTML omitted --><!-- raw HTML omitted -->这个101培训特别好，详细从run for school board到city council的具体细节，从最初筹划到募集签名和筹款，到campaign地点选择等；更重要的是如何平衡自己的本职工作、家庭生活和campaign。<!-- raw HTML omitted --><!-- raw HTML omitted -->很多人说politics改变不了自己生活，其实在美国，基层politics影响到自己生活方方面面：哪里修超市、哪里建养老院、建停车 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObFes01xF">新型冠状病毒SARS-CoV-2已经出现4年之久，几乎感染了全人类，那么在群体免疫已经建立的情况下，SARS-CoV-2感染会不会更轻微呢？牛津大学PLATCOV研究组在Lancet I...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obfes01xf/">
    
    
    
    
    
      
    
    新型冠状病毒SARS-CoV-2已经出现4年之久，几乎感染了全人类，那么在群体免疫已经建立的情况下，SARS-CoV-2感染会不会更轻微呢？<!-- raw HTML omitted --><!-- raw HTML omitted -->牛津大学PLATCOV研究组在Lancet ID发表了一项SARS-CoV-2治疗研究，对回答上述问题很有意义。研究评估了2021年到2023年年底感染SARS-CoV-2后的疾病进展（NCT05041907）。在入组的1262名多临床中心的患者中，发病7天后，病毒中位清除时间从2021年的16.6小时缩短到了2023年的9.2小时，对于未接受抗病毒药的患者而言，其7天病毒清除减少44%；而使用Paxlovid患者病毒清除减少26%。<!-- raw HTML omitted --><!-- raw HTML omitted -->这一数据提示，感染SARS-CoV-2后整体病毒清除时间缩短。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/4a994b1dgy1hp5g1ucsiaj217y4dfe81">https://tvax3.sinaimg.cn/large/4a994b1dgy1hp5g1ucsiaj217y4dfe81</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObCQcb0fv">#马书账# 在前往南宁的火车上，看完了这本《无责任的帝国-近代日本的扩张与毁灭》。如本书作者在前言所说，对于近代日本，我们既熟悉又陌生。熟悉是说我们对其所...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obcqcb0fv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#马书账#<!-- raw HTML omitted --><!-- raw HTML omitted --> 在前往南宁的火车上，看完了这本《无责任的帝国-近代日本的扩张与毁灭》。如本书作者在前言所说，对于近代日本，我们既熟悉又陌生。熟悉是说我们对其所作所为耳熟能详，乃至于刻骨铭心：但对这些行为背后的动因，往往只以一句帝国主义狼子野心概括之，未能知其所以然。<!-- raw HTML omitted --><!-- raw HTML omitted -->大部分相关主题的书籍，要么专注于果，论述其扩张侵略的具体实施过程；要么专注于因，论述经济、军事、外交、工业等促成日本扩张的各种客观因素。而这本书的重点，恰好落于因果之间，讲述“由因化果”的具体决策过程。它通过针对一个个政治 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObE40sRgX">这个电梯提示有点萌哎，感觉一按下去就会警铃大作，四面“唰”地落下铁栅栏。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obe40srgx/">
    
    
    
    
    
      
    
    这个电梯提示有点萌哎，感觉一按下去就会警铃大作，四面“唰”地落下铁栅栏。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObICAco2r">🔻……🔻来自网友分享，当风靠近时，能听到呼啸声。 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obicaco2r/">
    
    
    
    
    
      
    
    🔻……<!-- raw HTML omitted -->🔻来自网友分享，当风靠近时，能听到呼啸声。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/HL60LAn0lx08eq6JF">https://f.video.weibocdn.com/o0/HL60LAn0lx08eq6JF</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIeV9KPw">🔻从现场残骸来看，确实打下来了。🔻这美军被打下来的第几架了？ [图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obiev9kpw/">
    
    
    
    
    
      
    
    🔻从现场残骸来看，确实打下来了。<!-- raw HTML omitted -->🔻这美军被打下来的第几架了？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/larg">https://tvax2.sinaimg.cn/larg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIfl6FTF">🔻CNN：美国警方周六早上在波士顿东北大学校园清理“未经授权的露营地”时抓走了大约100人。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obifl6ftf/">
    
    
    
    
    
      
    
    🔻CNN：美国警方周六早上在波士顿东北大学校园清理“未经授权的露营地”时抓走了大约100人。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIhmsgbO">🔻美国也正在刮龙卷风，这是奥马哈-埃尔科恩，内布拉斯加州。🔻via weathernationtv.com🔻视频1是一个屋主在龙卷风袭击他家6分钟之前拍的，图2-4是袭击后...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obihmsgbo/">
    
    
    
    
    
      
    
    🔻美国也正在刮龙卷风，这是奥马哈-埃尔科恩，内布拉斯加州。<!-- raw HTML omitted -->🔻via weathernationtv.com<!-- raw HTML omitted -->🔻视频1是一个屋主在龙卷风袭击他家6分钟之前拍的，图2-4是袭击后，视频5是整个街区的情况。<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIhvgUrg">🔻有人抱着他的画和口号。🔻源：qudsnen.co [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obihvgurg/">
    
    
    
    
    
      
    
    🔻有人抱着他的画和口号。<!-- raw HTML omitted -->🔻源：qudsnen.co <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIi4a9sR">🔻然后老师们组成人墙的广场就变成图2这样了。🔻美国速度。#纽约大学老师组成人墙保护学生不被逮捕# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obii4a9sr/">
    
    
    
    
    
      
    
    🔻然后老师们组成人墙的广场就变成图2这样了。<!-- raw HTML omitted -->🔻美国速度。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#纽约大学老师组成人墙保护学生不被逮捕#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIiTySMa">🔻🇰🇵朝宣小型短片：平壤第一百货商店。🔻via KCNA 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obiitysma/">
    
    
    
    
    
      
    
    🔻🇰🇵朝宣小型短片：平壤第一百货商店。<!-- raw HTML omitted -->🔻via KCNA <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/tXb4o1x4lx08eq3p3J4">https://f.video.weibocdn.com/o0/tXb4o1x4lx08eq3p3J4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIkJDymG">🔻Man!🔻What Can i say? [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obikjdymg/">
    
    
    
    
    
      
    
    🔻Man!<!-- raw HTML omitted -->🔻What Can i say? <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIvjEcgH">你都看李唐了……//@白桃悠然:讲真抛开唇亡齿寒，我真觉得这个光之国真的很类人，从李唐讲的光之国就对这个果家没有好感，这就扯出一个问题，你认为独立自主很重...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obivjecgh/">
    
    
    
    
    
      
    
    你都看李唐了……//<!-- raw HTML omitted -->@白桃悠然<!-- raw HTML omitted -->:讲真抛开唇亡齿寒，我真觉得这个光之国真的很类人，从李唐讲的光之国就对这个果家没有好感，这就扯出一个问题，你认为独立自主很重要，还是人民生活好很重要。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻🇰🇵朝宣小型短片：平壤第一百货商店。<!-- raw HTML omitted -->🔻via KCNA <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIxsy71t">🔻连星星都不爱吃西兰花。🔻吃白人饭的是怎么忍的？🔻via 冯椿 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obixsy71t/">
    
    
    
    
    
      
    
    🔻连星星都不爱吃西兰花。<!-- raw HTML omitted -->🔻吃白人饭的是怎么忍的？<!-- raw HTML omitted -->🔻via 冯椿 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/vih1NA5Yl">https://f.video.weibocdn.com/o0/vih1NA5Yl</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/ObCQ1aA55">别来这个循环了我真的是怕了</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-obcq1aa55/">
    
    
    
    
    
      
    
    别来这个循环了我真的是怕了  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObENi2N9y">[悲伤]这是魔法 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obeni2n9y/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->这是魔法 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObFBKkGtE">重发。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obfbkkgte/">
    
    
    
    
    
      
    
    重发。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObFZctP82">真是福报，没钱也就算了，还得倒贴个心情</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obfzctp82/">
    
    
    
    
    
      
    
    真是福报，没钱也就算了，还得倒贴个心情  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObGkPEItg">烤鸭半只炒面一盘咖啡一杯番茄两只</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obgkpeitg/">
    
    
    
    
    
      
    
    烤鸭半只<!-- raw HTML omitted -->炒面一盘<!-- raw HTML omitted -->咖啡一杯<!-- raw HTML omitted -->番茄两只  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObHvQ43iz">一眼日帝代抽👿 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obhvq43iz/">
    
    
    
    
    
      
    
    一眼日帝代抽👿 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObF157yEq">宝宝你好漂亮🥹 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.nogista_ntv [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obf157yeq/">
    
    
    
    
    
      
    
    宝宝你好漂亮🥹<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogista_ntv &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hp5dmnfkbzj31xo1agdqp.jpg">https://tvax3.sinaimg.cn/large/006z6nxLgy1hp5dmnfkbzj31xo1agdqp.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObF16A0IX">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里乃木恋源：深海克苏鲁 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obf16a0ix/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->乃木恋<!-- raw HTML omitted --><!-- raw HTML omitted -->源：深海克苏鲁 &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5027780187062348%22">https://video.weibo.com/show?fid=1034:5027780187062348&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObFYMrqyu">啊啊啊啊啊啊好喜欢妹妹🥹🫰🏻</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obfymrqyu/">
    
    
    
    
    
      
    
    啊啊啊啊啊啊好喜欢妹妹🥹🫰🏻  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObFzyqbaZ">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月2nd写真集##女主角# 在阅读《女主角》之后感谢大家发布了很多关于山下美月2nd写真集《女主角》的感想�...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obfzyqbaz/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITOowtQ">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.松本美里 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitoowtq/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.松本美里 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hp5oaja1asj308c0690sq.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hp5oaja1asj308c0690sq.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITQfp1R">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.04.27 20:47「喵」久违地自拍了 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitqfp1r/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITTtd3j">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.04.27 20:48「这孩子真的好可爱」今天和可爱的孩子一起工作了虽然聊了很多但还是可爱到让...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitttd3j/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2315">https://m.weibo.cn/search?containerid=2315</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObDhyf6MK">嫂子5月3號要幫樂天金鷲始球式，日期和兩年前時間相近[哈哈] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obdhyf6mk/">
    
    
    
    
    
      
    
    嫂子5月3號要幫樂天金鷲始球式，日期和兩年前時間相近<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObGMi6hQJ">在別人的推特裡發現久保今天去看囉！ [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obgmi6hqj/">
    
    
    
    
    
      
    
    在別人的推特裡發現久保今天去看囉！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObDM1l1iz">棋手战鹰想起有段时间上证指数和中国围棋等级分差不多，现在轮到鹰酱身高和美元兑换日元的比拼了 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obdm1l1iz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted -->想起有段时间上证指数和中国围棋等级分差不多，现在轮到鹰酱身高和美元兑换日元的比拼了 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObE6n55qZ">我二老婆能坚持到我到衢州现场就已经不错了</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obe6n55qz/">
    
    
    
    
    
      
    
    我二老婆能坚持到我到衢州现场就已经不错了  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObEL905mk">上野梨纱：身为妹妹我可以锐评一下，我姐赢了前两轮的时候我也是大吃一惊。据说昨天我姐参加了中国围棋国家队的训练。今天这盘棋辜梓豪可以说完美躲过了我姐的大...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obel905mk/">
    
    
    
    
    
      
    
    上野梨纱：身为妹妹我可以锐评一下，我姐赢了前两轮的时候我也是大吃一惊。<!-- raw HTML omitted --><!-- raw HTML omitted -->据说昨天我姐参加了中国围棋国家队的训练。今天这盘棋辜梓豪可以说完美躲过了我姐的大锤子。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObGgHxIlr">日本代表团（？）#围棋# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obgghxilr/">
    
    
    
    
    
      
    
    日本代表团（？）<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObGqcpmQB">棋手战鹰哦哟 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obgqcpmqb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted -->哦哟 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObHpliBve">井山裕太赛后感想这几年我在世界大赛上一直没有很好的成绩，这一次虽然后续还有比赛，至少能收获当前的结果，感觉如释重负。之前每一场世界大赛，我都是拼尽全力...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obhplibve/">
    
    
    
    
    
      
    
    井山裕太赛后感想<!-- raw HTML omitted --><!-- raw HTML omitted -->这几年我在世界大赛上一直没有很好的成绩，这一次虽然后续还有比赛，至少能收获当前的结果，感觉如释重负。<!-- raw HTML omitted --><!-- raw HTML omitted -->之前每一场世界大赛，我都是拼尽全力面对，但是一直没有好的结果的话，说实话自己也想过今后还能不能参加世界大赛，所以这一次对我来说可谓“背水一战”。<!-- raw HTML omitted --><!-- raw HTML omitted -->第一轮面对亚运会个人赛金牌得主许皓鋐九段。这盘棋一直都非常难下，对我来说战胜强敌之后，为我之后的对局做了很好的铺垫。<!-- raw HTML omitted --><!-- raw HTML omitted -->下一轮会间隔一段时间，我依旧会集中精力面对这场比赛。<!-- raw HTML omitted --><!-- raw HTML omitted -->摘自：棋道web<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extpar">https://m.weibo.cn/p/index?extpar</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObEFWkpeE">久保史绪里via.nogista_ntv [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obefwkpee/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogista_ntv <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObEHni7rX">久保史绪里乃木恋源：深海克苏鲁 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obehni7rx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->乃木恋<!-- raw HTML omitted --><!-- raw HTML omitted -->源：深海克苏鲁 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObH5G9Y6Q">久保史绪里via.松本美里 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obh5g9y6q/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.松本美里 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObHVn3jh4">久保史绪里#久保史绪里手机博# 2024.04.27 20:47「喵」久违地自拍了 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obhvn3jh4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObI1CrE9Y">久保史绪里#久保史绪里手机博# 2024.04.27 20:48「这孩子真的好可爱」今天和可爱的孩子一起工作了虽然聊了很多但还是可爱到让我爱意满溢而已我太喜欢她了，这个...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obi1cre9y/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/ObEiTC2qq">柯洁#第二届衢州烂柯杯世界围棋公开赛##赛事报道# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-obeitc2qq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;extparam=">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;extparam=</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/ObG8tdQPZ">柯洁#第二届衢州烂柯杯世界围棋公开赛##赛果发布# 柯洁九段执白290手负姜东润九段。止步16强。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-obg8tdqpz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;ext">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;ext</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/646245714/answer/3480857441">王诗翔回答了问题: 为什么雷军这样一个羞涩内向的理工男，却能够屡次创业成功，开创好几番大事业?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-646245714-answer-3480857441/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/cn/2024/04/27/ai-for-science/">科研用人工智能</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-cn-2024-04-27-ai-for-science/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/689615842">王诗翔赞同了文章: 人民日报推荐2024年必读的80本经典书籍，你们都读过哪几本？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-689615842/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694862355">量子位发表了文章: 激进式押注AI手机的厂商一大堆，为什么登顶的是它家</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694862355/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694871540">量子位发表了文章: 阿里智能体“组装工厂”开源！0经验搞定上万Agent并发</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694871540/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694888617">量子位发表了文章: Llama 3低比特量化性能下降显著！全面评估结果来了 | 港大&amp;北航&amp;ETH</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694888617/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694888826">量子位发表了文章: 清华团队国产“Sora”火了！画面效果对标OpenAI，长度可达16秒，还能读懂物理规律</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694888826/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

